CoChat

HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk

Helminen, Olli, Aspholm, Susanna, Pokka, Tytti, Hautakangas, Milla-Riikka, Haatanen, Nora, Lempainen, Johanna, Ilonen, Jorma, Simell, Olli, Knip, Mikael, Veijola, Riitta · 2015 · Diabetes
Cited by 85

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Prediction of type 1 diabetes is based on the detection of multiple islet autoantibodies in subjects who are at increased genetic risk. Prediction of the timing of diagnosis is challenging, however. We assessed the utility of HbA1c levels in predicting the clinical disease in genetically predisposed children with multiple autoantibodies. Cord blood samples from 168,055 newborn infants were screened for class II HLA genotypes in Finland, and 14,876 children with increased genetic risk for type 1 diabetes were invited to participate in regular follow-ups, including screening for diabetes-associated autoantibodies. When two or more autoantibodies were detected, HbA1c levels were analyzed at each visit. During follow-up, multiple (two or more) autoantibodies developed in 466 children; type 1 diabetes was diagnosed in 201 of these children (43%, progressors), while 265 children remained disease free (nonprogressors) by December 2011. A 10% increase in HbA1c levels in samples obtained 3–12 months apart predicted the diagnosis of clinical disease (hazard ratio [HR] 5.7 [95% CI 4.1–7.9]) after a median time of 1.1 years (interquartile range [IQR] 0.6–3.1 years) from the observed rise of HbA1c. If the HbA1c level was ≥5.9% (41 mmol/mol) in two consecutive samples, the median time to diagnosis was 0.9 years (IQR 0.3–1.5, HR 11.9 [95% CI 8.8–16.0]). In conclusion, HbA1c is a useful biochemical marker when predicting the time to diagnosis of type 1 diabetes in children with multiple autoantibodies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db14-0497

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 85

Metadata

Authors
Helminen, O., Aspholm, S., Pokka, T., Hautakangas, M.-R., Haatanen, N., Lempainen, J., Ilonen, J., Simell, O., Knip, M., & Veijola, R.
Venue
Diabetes
Published
2014-12-18
Volume
64
Issue
5
Pages
1719-1727
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2130601108
Cited by
85
References
11
FWCI
4.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk. https://app.cochat.ai/papers/10.2337/db14-0497
The paper
Helminen, O., Aspholm, S., Pokka, T., Hautakangas, M.-R., Haatanen, N., Lempainen, J., Ilonen, J., Simell, O., Knip, M., & Veijola, R. (2015). HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk. Diabetes. https://doi.org/10.2337/db14-0497

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.